vimarsana.com
Home
Live Updates
Voxelotor for Sickle Cell Anemia Now Down to 4-Year-Olds : v
Voxelotor for Sickle Cell Anemia Now Down to 4-Year-Olds : v
Voxelotor for Sickle Cell Anemia Now Down to 4-Year-Olds
The indication has been extended down to children aged 4 years, and the FDA also approved a child-friendly, grape-flavored formulation.
Related Keywords
Voxelotor Oxbryta ,
,
Ted Love ,
Global Blood Therapeutics ,
Sickle Cell ,
Children ,
Child ,
Childhood ,
Ediatrics ,
Kids ,
Hematology ,
Physician Assistants ,
Abdominal Pain ,
Anemia ,
Fever ,
Us Food And Drug Administration ,
Nited States Food And Drug Administration ,
Fda ,
Hemoglobin ,
Emoglobin Hb ,
Emoglobin Hgb ,
Hemolytic Anemia ,
Hyperthermia ,
Heat Exhaustion ,
Heat Prostration ,
Pain Management ,